Linked Life Data

19139369

Source:http://linkedlifedata.com/resource/pubmed/id/19139369

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2009-1-13
pubmed:abstractText
The frequency of HIV dementia in a recent study of HIV+ individuals at the Infectious Disease Institute in Kampala, Uganda, was 31%. Coformulated generic drugs, which include stavudine, are the most common regimens to treat HIV infection in Uganda and many other parts of Africa.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19139369-10331692, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139369-10787000, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139369-10851375, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139369-12084874, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139369-12491162, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139369-15097298, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139369-16103767, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139369-16864825, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139369-17261681, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139369-2839106, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139369-2843154, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139369-3053922, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139369-3233245, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139369-8279929
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1526-632X
pubmed:author
pubmed:issnType
Electronic
pubmed:day
13
pubmed:volume
72
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
165-70
pubmed:dateRevised
2010-9-23
pubmed:meshHeading
pubmed-meshheading:19139369-AIDS Dementia Complex, pubmed-meshheading:19139369-Acquired Immunodeficiency Syndrome, pubmed-meshheading:19139369-Adult, pubmed-meshheading:19139369-Anti-HIV Agents, pubmed-meshheading:19139369-Antiretroviral Therapy, Highly Active, pubmed-meshheading:19139369-Cognition Disorders, pubmed-meshheading:19139369-Developing Countries, pubmed-meshheading:19139369-Disability Evaluation, pubmed-meshheading:19139369-Female, pubmed-meshheading:19139369-Humans, pubmed-meshheading:19139369-Male, pubmed-meshheading:19139369-Neuropsychological Tests, pubmed-meshheading:19139369-Outcome Assessment (Health Care), pubmed-meshheading:19139369-Risk Assessment, pubmed-meshheading:19139369-Stavudine, pubmed-meshheading:19139369-Treatment Outcome, pubmed-meshheading:19139369-Uganda
pubmed:year
2009
pubmed:articleTitle
Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda.
pubmed:affiliation
Department of Neurology, Johns Hopkins Bayview Medical Center, Baltimore, MD 21224, USA. sacktor@jhmi.edu
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, N.I.H., Extramural